Fred E Cooperrider

Array ( [id] => 575769 [patent_doc_number] => 07456014 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-25 [patent_title] => 'Recombinant constructs and their use in reducing gene expression' [patent_app_type] => utility [patent_app_number] => 11/476510 [patent_app_country] => US [patent_app_date] => 2006-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23237 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/456/07456014.pdf [firstpage_image] =>[orig_patent_app_number] => 11476510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8629905 [patent_doc_number] => 08361977 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Compositions and methods for modulation of SMN2 splicing' [patent_app_type] => utility [patent_app_number] => 11/993609 [patent_app_country] => US [patent_app_date] => 2006-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13414 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11993609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5219275 [patent_doc_number] => 20070160586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Methods for extending the replicative lifespan of cells' [patent_app_type] => utility [patent_app_number] => 11/453283 [patent_app_country] => US [patent_app_date] => 2006-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 20400 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20070160586.pdf [firstpage_image] =>[orig_patent_app_number] => 11453283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4469928 [patent_doc_number] => 07943589 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-17 [patent_title] => 'siRNA microbicides for preventing and treating diseases' [patent_app_type] => utility [patent_app_number] => 11/916334 [patent_app_country] => US [patent_app_date] => 2006-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16744 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/943/07943589.pdf [firstpage_image] =>[orig_patent_app_number] => 11916334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5154882 [patent_doc_number] => 20070037765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Formulations comprising antisense nucleotides to connexins' [patent_app_type] => utility [patent_app_number] => 11/447599 [patent_app_country] => US [patent_app_date] => 2006-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10789 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037765.pdf [firstpage_image] =>[orig_patent_app_number] => 11447599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446093 [patent_doc_number] => 20090047319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Pharmaceutical composition for obstructive vascular disease' [patent_app_type] => utility [patent_app_number] => 11/921020 [patent_app_country] => US [patent_app_date] => 2006-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7186 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047319.pdf [firstpage_image] =>[orig_patent_app_number] => 11921020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4740565 [patent_doc_number] => 20080234218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Sirna For Inhibiting Il-6 Expression and Composition Containing Them' [patent_app_type] => utility [patent_app_number] => 11/915009 [patent_app_country] => US [patent_app_date] => 2006-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4278 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234218.pdf [firstpage_image] =>[orig_patent_app_number] => 11915009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7977625 [patent_doc_number] => 08071559 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Compositions and methods for cancer diagnosis and treatment' [patent_app_type] => utility [patent_app_number] => 11/416854 [patent_app_country] => US [patent_app_date] => 2006-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19017 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071559.pdf [firstpage_image] =>[orig_patent_app_number] => 11416854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4808139 [patent_doc_number] => 20080171717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Double-Stranded Synthetic Oligonucleotides Useful For Inducing Apoptosis of Osteoclasts For the Treatment of Osteopenic Pathologies' [patent_app_type] => utility [patent_app_number] => 11/910086 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4729 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171717.pdf [firstpage_image] =>[orig_patent_app_number] => 11910086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5754626 [patent_doc_number] => 20060223775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Nucleotide sequence for treating cancer and infection' [patent_app_type] => utility [patent_app_number] => 11/386531 [patent_app_country] => US [patent_app_date] => 2006-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12079 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223775.pdf [firstpage_image] =>[orig_patent_app_number] => 11386531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6098075 [patent_doc_number] => 20110003879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Antisense oligonucleotides targeted to the coding region of thymidylate synthase and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/908389 [patent_app_country] => US [patent_app_date] => 2006-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20404 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003879.pdf [firstpage_image] =>[orig_patent_app_number] => 11908389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 586349 [patent_doc_number] => 07439059 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Compositions and methods for activating genes of interest' [patent_app_type] => utility [patent_app_number] => 11/363425 [patent_app_country] => US [patent_app_date] => 2006-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6759 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/439/07439059.pdf [firstpage_image] =>[orig_patent_app_number] => 11363425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149481 [patent_doc_number] => 20070049541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Method for the modulation of function of transcription factors' [patent_app_type] => utility [patent_app_number] => 11/358688 [patent_app_country] => US [patent_app_date] => 2006-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8668 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049541.pdf [firstpage_image] =>[orig_patent_app_number] => 11358688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4922541 [patent_doc_number] => 20080070857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Pharmaceutical Agents for Preventing Metastasis of Cancer' [patent_app_type] => utility [patent_app_number] => 11/884210 [patent_app_country] => US [patent_app_date] => 2006-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6323 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070857.pdf [firstpage_image] =>[orig_patent_app_number] => 11884210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501591 [patent_doc_number] => 20090162279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Oligonucleotide or Its Functional Homologue, a Composition Comprising the Same and a Method of Treating B Cell Neoplasm' [patent_app_type] => utility [patent_app_number] => 11/914745 [patent_app_country] => US [patent_app_date] => 2006-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6789 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162279.pdf [firstpage_image] =>[orig_patent_app_number] => 11914745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479610 [patent_doc_number] => 20090202567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'OLIGONUCLEOTIDES OR THEIR FUNCTIONAL HOMOLOGUES, A COMPOSITION COMPRISING THE SAME AND A METHOD OF TREATING B CELL NEOPLASM' [patent_app_type] => utility [patent_app_number] => 11/914744 [patent_app_country] => US [patent_app_date] => 2006-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6901 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202567.pdf [firstpage_image] =>[orig_patent_app_number] => 11914744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5672978 [patent_doc_number] => 20060178333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/346145 [patent_app_country] => US [patent_app_date] => 2006-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 15261 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178333.pdf [firstpage_image] =>[orig_patent_app_number] => 11346145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667613 [patent_doc_number] => 20060172963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'RNAi-mediated inhibition of ocular hypertension targets' [patent_app_type] => utility [patent_app_number] => 11/344702 [patent_app_country] => US [patent_app_date] => 2006-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19104 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172963.pdf [firstpage_image] =>[orig_patent_app_number] => 11344702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667615 [patent_doc_number] => 20060172965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'RNAi-mediated inhibition of ocular targets' [patent_app_type] => utility [patent_app_number] => 11/345361 [patent_app_country] => US [patent_app_date] => 2006-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19147 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172965.pdf [firstpage_image] =>[orig_patent_app_number] => 11345361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515561 [patent_doc_number] => 20090215868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Therapeutic Medicament for Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, and Pulmonary Hypertension' [patent_app_type] => utility [patent_app_number] => 11/794167 [patent_app_country] => US [patent_app_date] => 2006-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3371 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215868.pdf [firstpage_image] =>[orig_patent_app_number] => 11794167 [rel_patent_id] =>[rel_patent_doc_number] =>)